1. Home
  2. WLGS vs MYNZ Comparison

WLGS vs MYNZ Comparison

Compare WLGS & MYNZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WLGS
  • MYNZ
  • Stock Information
  • Founded
  • WLGS 1981
  • MYNZ 2021
  • Country
  • WLGS Hong Kong
  • MYNZ Germany
  • Employees
  • WLGS N/A
  • MYNZ N/A
  • Industry
  • WLGS Engineering & Construction
  • MYNZ Biotechnology: Pharmaceutical Preparations
  • Sector
  • WLGS Consumer Discretionary
  • MYNZ Health Care
  • Exchange
  • WLGS Nasdaq
  • MYNZ Nasdaq
  • Market Cap
  • WLGS 8.5M
  • MYNZ 9.8M
  • IPO Year
  • WLGS 2023
  • MYNZ 2021
  • Fundamental
  • Price
  • WLGS $0.56
  • MYNZ $0.48
  • Analyst Decision
  • WLGS
  • MYNZ Buy
  • Analyst Count
  • WLGS 0
  • MYNZ 2
  • Target Price
  • WLGS N/A
  • MYNZ $3.00
  • AVG Volume (30 Days)
  • WLGS 125.5K
  • MYNZ 1.3M
  • Earning Date
  • WLGS 08-02-2024
  • MYNZ 08-13-2024
  • Dividend Yield
  • WLGS N/A
  • MYNZ N/A
  • EPS Growth
  • WLGS N/A
  • MYNZ N/A
  • EPS
  • WLGS N/A
  • MYNZ N/A
  • Revenue
  • WLGS $6,825,879.00
  • MYNZ $895,479.00
  • Revenue This Year
  • WLGS N/A
  • MYNZ $67.40
  • Revenue Next Year
  • WLGS N/A
  • MYNZ $191.13
  • P/E Ratio
  • WLGS N/A
  • MYNZ N/A
  • Revenue Growth
  • WLGS 65.07
  • MYNZ 69.00
  • 52 Week Low
  • WLGS $0.40
  • MYNZ $0.32
  • 52 Week High
  • WLGS $1.46
  • MYNZ $4.90
  • Technical
  • Relative Strength Index (RSI)
  • WLGS 46.70
  • MYNZ 47.27
  • Support Level
  • WLGS $0.52
  • MYNZ $0.39
  • Resistance Level
  • WLGS $0.60
  • MYNZ $0.56
  • Average True Range (ATR)
  • WLGS 0.05
  • MYNZ 0.09
  • MACD
  • WLGS -0.01
  • MYNZ 0.02
  • Stochastic Oscillator
  • WLGS 13.33
  • MYNZ 66.45

About WLGS Wang & Lee Group Inc.

WANG & LEE Group Inc operates as an investment holding company. The firm conducts its primary operations through its indirectly wholly owned subsidiary WANG and LEE CONTRACTING LIMITED (WLHK). WLHK provides contract engineering, installation, and out-fitting of the following products and services: low voltage (220v/phase 1 or 380v/phase 3) electrical systems, mechanical ventilation and air-conditioning systems (MVAC), fire safety systems, and water supply and sewage disposal systems.

About MYNZ Mainz Biomed N.V.

Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples.

Share on Social Networks: